Amferia AB
559170-1262ActiveDeveloping peptide hydrogel technology to combat bacterial infections safely.
Biotechnology / Medical Device Company (SME)amferia.com
Overview
- 5–9
- Employees
- 1–49K SEK
- Revenue
- 2018
- Founded
Description
Amferia is a Swedish biotechnology company specializing in developing advanced antimicrobial solutions derived from fundamental research at Chalmers University of Technology. The core of their innovation is a patented peptide-hydrogel platform that safely utilizes antimicrobial peptides to kill near...
Tags
B2BPharmaceuticals
Keywords
Antibiotic Resistance